Navigation Links
Chemists design molecules for controlling bacterial behavior
Date:5/13/2014

Chemists in the College of Arts and Sciences have figured out how to control multiple bacterial behaviorspotentially good news for the treatment of infectious diseases and other bacteria-associated issues, without causing drug resistance.

Yan-Yeung Luk, associate professor of chemistry, has spearheaded the discovery, in conjunction with his research lab at Syracuse University and the Wang Lab at SUNY Upstate Medical University. Their findings are the subject of a forthcoming article in the journal ChemBioChem (John Wiley & Sons Inc.).

"Since the discovery of the first antibiotic, penicillin, in 1928, bacteria have become smarter and have developed resistance to many drugs," says Luk, an expert in bio-organic chemistry, nanomaterials and chemical biology. "They've done this by altering their genetic make-up; transferring drug-resistant genes between one another; and creating biofilms, which are multicellular communities where bacteria can be a thousand-fold more resistant to antibiotics."

In response, Luk's team has developed a class of chemical agents that does not kill bacteria but, rather, changes their multicellular behaviors. These agents are called disaccharide derivatives, and they mimic a class of natural molecules known as rhamnolipids, which are produced and secreted by the bacterium itself.

Luk says that while non-microbicidal (i.e., "non-killing") molecules are nothing new, his are unique because they target a new, yet-to-be-explained set of biological receptors.

"Rhamnolipids modulate at least three multicellular bioactivities in Pseudomonas aeruginosa," says Luk, referring to the rod-shaped bacterium that causes disease in animals and humans. "The synthetic molecules made by our lab don't exactly look like rhamnolipids, but they can control bioactivities, such as swarming movements, surface adhesion and biofilm formation."

This class, he adds, is non-microbicidal with a wide variety of microbes, thus giving it broad commercial value. It also has the potential to inhibit horizontal gene transferthe process by which bacteria share genetic information, such as the ability to be drug-resistant.

In the near future, Luk's team plans to unveil another class of molecules they have designed that not only mimics but also dominates the activities of rhamnolipids.

"Rhamnolipids are already on the market, but our product, with its synthetic flexibility, has just as many applications and may be improved rationally by synthetic design," says Luk, who also holds courtesy appointments in the Department of Biology in the College of Arts and Sciences and in the Department of Biomedical and Chemical Engineering in the College of Engineering and Computer Science. "All of this is subject to ongoing research."


'/>"/>

Contact: Rob Enslin
rmenslin@syr.edu
315-443-3403
Syracuse University
Source:Eurekalert  

Related biology news :

1. Inspired by moth eyeballs, UC Irvine chemists develop gold coating that dims glare
2. Chemists work with small peptide chains may revolutionize study of enzymes and diseases
3. Notre Dame chemists discover new class of antibiotics
4. Mentoring the next generation of black chemists (video)
5. CCNY chemists use sugar-based gelators to solidify vegetable oils
6. Biochemists find incomplete protein digestion is a useful thing for some bacteria
7. CCNY chemists devise new way to prepare molecules for drug testing
8. Biochemists uphold law of physics
9. University of Wisconsin chemists find new compounds to curb staph infection
10. UCI chemists devise inexpensive, accurate way to detect prostate cancer
11. Chemists devise inexpensive, benchtop method for marking and selecting cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chemists design molecules for controlling bacterial behavior
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
Breaking Biology Technology: